440 related articles for article (PubMed ID: 28233705)
1. [Not Available].
Grabli D
Presse Med; 2017 Mar; 46(2 Pt 1):187-194. PubMed ID: 28233705
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of motor fluctuations in Parkinson's disease.
Widnell K
Mov Disord; 2005; 20 Suppl 11():S17-22. PubMed ID: 15822108
[TBL] [Abstract][Full Text] [Related]
3. Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.
Vu TC; Nutt JG; Holford NH
Br J Clin Pharmacol; 2012 Aug; 74(2):267-83. PubMed ID: 22283961
[TBL] [Abstract][Full Text] [Related]
4. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia.
Bartels AL; Balash Y; Gurevich T; Schaafsma JD; Hausdorff JM; Giladi N
J Clin Neurosci; 2003 Sep; 10(5):584-8. PubMed ID: 12948464
[TBL] [Abstract][Full Text] [Related]
5. Nigrostriatal dysfunction in patients with amyotrophic lateral sclerosis and parkinsonism.
Park HK; Lim YM; Kim JS; Lee MC; Kim SM; Kim BJ; Kim KK
J Neurol Sci; 2011 Feb; 301(1-2):12-3. PubMed ID: 21167502
[TBL] [Abstract][Full Text] [Related]
6. The Motor Syndrome of Parkinson's Disease.
Erro R; Stamelou M
Int Rev Neurobiol; 2017; 132():25-32. PubMed ID: 28554410
[TBL] [Abstract][Full Text] [Related]
7. Impaired finger dexterity and nigrostriatal dopamine loss in Parkinson's disease.
Lee SH; Lee MJ; Lyoo CH; Cho H; Lee MS
J Neural Transm (Vienna); 2018 Sep; 125(9):1333-1339. PubMed ID: 29971496
[TBL] [Abstract][Full Text] [Related]
8. [Current preclinical findings on substances against Parkinson's disease].
Gerlach M; Riederer P
Nervenarzt; 2003 Mar; 74 Suppl 1():S2-6. PubMed ID: 12624677
[TBL] [Abstract][Full Text] [Related]
9. Postural control, gait, and dopamine functions in parkinsonian movement disorders.
Bohnen NI; Cham R
Clin Geriatr Med; 2006 Nov; 22(4):797-812, vi. PubMed ID: 17000336
[TBL] [Abstract][Full Text] [Related]
10. Factors contributing to fluctuations of the dopaminergic nigro-striatal feedback system in Parkinson's disease.
Riederer P
J Neural Transm Suppl; 1988; 27():191-9. PubMed ID: 3165434
[TBL] [Abstract][Full Text] [Related]
11. [Gait and balance disorders in patients with atypical parkinsonian syndromes].
Welter ML; Westby GW; Chastan N
Rev Neurol (Paris); 2010 Feb; 166(2):188-95. PubMed ID: 19656539
[TBL] [Abstract][Full Text] [Related]
12. Rapid-onset dystonia-parkinsonism: case report.
Svetel M; Ozelius LJ; Buckley A; Lohmann K; Brajković L; Klein C; Kostić VS
J Neurol; 2010 Mar; 257(3):472-4. PubMed ID: 19936820
[No Abstract] [Full Text] [Related]
13. Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).
Stocchi F; Marconi S
Clin Neuropharmacol; 2010 Jul; 33(4):198-203. PubMed ID: 20414107
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of Parkinson disease.
Stacy M
Neurol Clin; 2009 Aug; 27(3):605-31, v. PubMed ID: 19555824
[TBL] [Abstract][Full Text] [Related]
15. Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study.
Poston KL; Ua Cruadhlaoich MAI; Santoso LF; Bernstein JD; Liu T; Wang Y; Rutt B; Kerchner GA; Zeineh MM
J Parkinsons Dis; 2020; 10(2):591-604. PubMed ID: 32250317
[TBL] [Abstract][Full Text] [Related]
16. [Pergolide: a useful agonist for the treatment of Parkinson disease].
Bonnet AM; Houeto JL
Rev Neurol (Paris); 2002 Jul; 158(6-7):744-5. PubMed ID: 12486908
[TBL] [Abstract][Full Text] [Related]
17. An approach to the continuous dopaminergic stimulation in Parkinson's disease.
Schwartz M; Sabetay S
Isr Med Assoc J; 2012 Mar; 14(3):175-9. PubMed ID: 22675859
[TBL] [Abstract][Full Text] [Related]
18. New directions in the drug treatment of Parkinson's disease.
Montastruc JL; Rascol O; Senard JM
Drugs Aging; 1996 Sep; 9(3):169-84. PubMed ID: 8877311
[TBL] [Abstract][Full Text] [Related]
19. [Medicinal treatment of idiopathic Parkinson's disease].
Klockgether T
Nervenarzt; 2003 Mar; 74 Suppl 1():S12-21. PubMed ID: 12624679
[TBL] [Abstract][Full Text] [Related]
20. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
